The Drug Controller General of India has approved an anti-Covid oral drug for emergency use as an adjunct therapy. It has been developed by the Defence Research and Development Organisation, Institute of Nuclear Medicine and Allied Sciences and Dr Reddy's Laboratories. > This will help in a faster recovery of Covid-19 patients who are hospitalised. Watch: India gets new Covid medicine, developed by DRDO: How it works, how to use> This will also ensure that Covid-19 patients do not need oxygen supplement. Dr Anant Narayan said work is on to bring the drug to the market in cooperation with Dr Reddy's Laboratories.

Source: Hindustan Times May 08, 2021 14:49 UTC